Skip to content
Homepage
Author:
Two Bear Capital
Posted Date:
May 19, 2026
Selector Launches AI-Powered Multi-Cloud Observability Solution, Closing the Network-to-Cloud Visibility Gap
Two Bear Capital
May 19, 2026
Inimmune Completes Enrollment and Doses First Patient in Phase 2 Chamber Trial of INI-2004 for Allergic Rhinitis
Two Bear Capital
March 12, 2026
Inimmune Strengthens Leadership Team Ahead of Phase 2 INI-2004 Allergic Rhinitis Data Readout
Two Bear Capital
March 5, 2026
PULSEDATA AI ANNOUNCES STRATEGIC PARTNERSHIP WITH CALCIUM HEALTH TO STRENGTHEN CHRONIC CONDITION MANAGEMENT IN VALUE-BASED CARE
Two Bear Capital
February 24, 2026
Selector Raises $32 Million to Eliminate Downtime with AI-Powered Observability
Two Bear Capital
February 18, 2026
FYR Bio Appoints Barbara K. Zehentner, MBA, PhD, HCLD (ABB), as Chief Operating Officer
Two Bear Capital
February 10, 2026
